Cholecystokinin promotes sleep and reduces food intake in diabetic rats

Levente Kapás, Ferenc Obál, Ibolya Farkas, Linda C. Payne, G. Sáry, György Rubicsek, James M. Krueger

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

It has been reported that systemic injections of cholecystokinin (CCK) elicit the behavioral characteristics of satiety, including sleep, in rats. CCK is a potent stimulator of insulin secretion, and insulin is hypothesized to be involved in sleep and feeding regulation. The purpose of the current experiments was to study the possible role of endogenous insulin in the food-intake-reducing and hypnogenic effects of intraperitoneally (IP) administered CCK. Normal and streptozotocin (STR)-diabetic rats were injected with isotonic saline or CCK (10 and 50 μg/kg) at dark onset, and sleep-wake activity was determined for the next 12 h. There were no significant differences between the baseline sleep-wake activity of normal and diabetic rats. IP injection of CCK elicited a selective increase in nonrapideye-movement sleep in both groups during the first postinjection hour. In a separate experiment, the effects of CCK (10 μg/kg) on food intake were determined in control and diabetic rats; CCK suppressed the 1-h food intake in both groups. In a third experiment, the effects of CCK treatment (50 μg/kg) on plasma insulin levels were determined. In normal rats, CCK elicited a two-fold increase in plasma insulin concentration, whereas diabetic rats had a significantly lower basal insulin level which was not affected by CCK treatment. We conclude that hypnogenic and food-intake-reducing effects of exogenously administered CCK are closely associated; however, pancreatic insulin does not play a significant role in either of these effects.

Original languageEnglish
Pages (from-to)417-420
Number of pages4
JournalPhysiology and Behavior
Volume50
Issue number2
DOIs
Publication statusPublished - 1991

Fingerprint

Cholecystokinin
Sleep
Eating
Insulin
Injections
Streptozocin

Keywords

  • Cholecystokinin
  • Food intake
  • Insulin
  • Rat
  • Sleep
  • Streptozotocin

ASJC Scopus subject areas

  • Physiology (medical)
  • Behavioral Neuroscience

Cite this

Kapás, L., Obál, F., Farkas, I., Payne, L. C., Sáry, G., Rubicsek, G., & Krueger, J. M. (1991). Cholecystokinin promotes sleep and reduces food intake in diabetic rats. Physiology and Behavior, 50(2), 417-420. https://doi.org/10.1016/0031-9384(91)90088-6

Cholecystokinin promotes sleep and reduces food intake in diabetic rats. / Kapás, Levente; Obál, Ferenc; Farkas, Ibolya; Payne, Linda C.; Sáry, G.; Rubicsek, György; Krueger, James M.

In: Physiology and Behavior, Vol. 50, No. 2, 1991, p. 417-420.

Research output: Contribution to journalArticle

Kapás, L, Obál, F, Farkas, I, Payne, LC, Sáry, G, Rubicsek, G & Krueger, JM 1991, 'Cholecystokinin promotes sleep and reduces food intake in diabetic rats', Physiology and Behavior, vol. 50, no. 2, pp. 417-420. https://doi.org/10.1016/0031-9384(91)90088-6
Kapás, Levente ; Obál, Ferenc ; Farkas, Ibolya ; Payne, Linda C. ; Sáry, G. ; Rubicsek, György ; Krueger, James M. / Cholecystokinin promotes sleep and reduces food intake in diabetic rats. In: Physiology and Behavior. 1991 ; Vol. 50, No. 2. pp. 417-420.
@article{b9ebaa2723d24b2d924691facab2ddcb,
title = "Cholecystokinin promotes sleep and reduces food intake in diabetic rats",
abstract = "It has been reported that systemic injections of cholecystokinin (CCK) elicit the behavioral characteristics of satiety, including sleep, in rats. CCK is a potent stimulator of insulin secretion, and insulin is hypothesized to be involved in sleep and feeding regulation. The purpose of the current experiments was to study the possible role of endogenous insulin in the food-intake-reducing and hypnogenic effects of intraperitoneally (IP) administered CCK. Normal and streptozotocin (STR)-diabetic rats were injected with isotonic saline or CCK (10 and 50 μg/kg) at dark onset, and sleep-wake activity was determined for the next 12 h. There were no significant differences between the baseline sleep-wake activity of normal and diabetic rats. IP injection of CCK elicited a selective increase in nonrapideye-movement sleep in both groups during the first postinjection hour. In a separate experiment, the effects of CCK (10 μg/kg) on food intake were determined in control and diabetic rats; CCK suppressed the 1-h food intake in both groups. In a third experiment, the effects of CCK treatment (50 μg/kg) on plasma insulin levels were determined. In normal rats, CCK elicited a two-fold increase in plasma insulin concentration, whereas diabetic rats had a significantly lower basal insulin level which was not affected by CCK treatment. We conclude that hypnogenic and food-intake-reducing effects of exogenously administered CCK are closely associated; however, pancreatic insulin does not play a significant role in either of these effects.",
keywords = "Cholecystokinin, Food intake, Insulin, Rat, Sleep, Streptozotocin",
author = "Levente Kap{\'a}s and Ferenc Ob{\'a}l and Ibolya Farkas and Payne, {Linda C.} and G. S{\'a}ry and Gy{\"o}rgy Rubicsek and Krueger, {James M.}",
year = "1991",
doi = "10.1016/0031-9384(91)90088-6",
language = "English",
volume = "50",
pages = "417--420",
journal = "Physiology and Behavior",
issn = "0031-9384",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Cholecystokinin promotes sleep and reduces food intake in diabetic rats

AU - Kapás, Levente

AU - Obál, Ferenc

AU - Farkas, Ibolya

AU - Payne, Linda C.

AU - Sáry, G.

AU - Rubicsek, György

AU - Krueger, James M.

PY - 1991

Y1 - 1991

N2 - It has been reported that systemic injections of cholecystokinin (CCK) elicit the behavioral characteristics of satiety, including sleep, in rats. CCK is a potent stimulator of insulin secretion, and insulin is hypothesized to be involved in sleep and feeding regulation. The purpose of the current experiments was to study the possible role of endogenous insulin in the food-intake-reducing and hypnogenic effects of intraperitoneally (IP) administered CCK. Normal and streptozotocin (STR)-diabetic rats were injected with isotonic saline or CCK (10 and 50 μg/kg) at dark onset, and sleep-wake activity was determined for the next 12 h. There were no significant differences between the baseline sleep-wake activity of normal and diabetic rats. IP injection of CCK elicited a selective increase in nonrapideye-movement sleep in both groups during the first postinjection hour. In a separate experiment, the effects of CCK (10 μg/kg) on food intake were determined in control and diabetic rats; CCK suppressed the 1-h food intake in both groups. In a third experiment, the effects of CCK treatment (50 μg/kg) on plasma insulin levels were determined. In normal rats, CCK elicited a two-fold increase in plasma insulin concentration, whereas diabetic rats had a significantly lower basal insulin level which was not affected by CCK treatment. We conclude that hypnogenic and food-intake-reducing effects of exogenously administered CCK are closely associated; however, pancreatic insulin does not play a significant role in either of these effects.

AB - It has been reported that systemic injections of cholecystokinin (CCK) elicit the behavioral characteristics of satiety, including sleep, in rats. CCK is a potent stimulator of insulin secretion, and insulin is hypothesized to be involved in sleep and feeding regulation. The purpose of the current experiments was to study the possible role of endogenous insulin in the food-intake-reducing and hypnogenic effects of intraperitoneally (IP) administered CCK. Normal and streptozotocin (STR)-diabetic rats were injected with isotonic saline or CCK (10 and 50 μg/kg) at dark onset, and sleep-wake activity was determined for the next 12 h. There were no significant differences between the baseline sleep-wake activity of normal and diabetic rats. IP injection of CCK elicited a selective increase in nonrapideye-movement sleep in both groups during the first postinjection hour. In a separate experiment, the effects of CCK (10 μg/kg) on food intake were determined in control and diabetic rats; CCK suppressed the 1-h food intake in both groups. In a third experiment, the effects of CCK treatment (50 μg/kg) on plasma insulin levels were determined. In normal rats, CCK elicited a two-fold increase in plasma insulin concentration, whereas diabetic rats had a significantly lower basal insulin level which was not affected by CCK treatment. We conclude that hypnogenic and food-intake-reducing effects of exogenously administered CCK are closely associated; however, pancreatic insulin does not play a significant role in either of these effects.

KW - Cholecystokinin

KW - Food intake

KW - Insulin

KW - Rat

KW - Sleep

KW - Streptozotocin

UR - http://www.scopus.com/inward/record.url?scp=0025737750&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025737750&partnerID=8YFLogxK

U2 - 10.1016/0031-9384(91)90088-6

DO - 10.1016/0031-9384(91)90088-6

M3 - Article

C2 - 1745688

AN - SCOPUS:0025737750

VL - 50

SP - 417

EP - 420

JO - Physiology and Behavior

JF - Physiology and Behavior

SN - 0031-9384

IS - 2

ER -